Overview

Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD

Status:
NOT_YET_RECRUITING
Trial end date:
2028-07-01
Target enrollment:
Participant gender:
Summary
This study investigates DDH-LSD, a novel LSD-like compound expected to have a shorter duration of action than LSD. In healthy volunteers, pharmacokinetics, safety, and subjective effects, will be assessed and compare with LSD in a controlled cross-over study.
Phase:
NA
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Treatments:
Lysergic Acid Diethylamide